Traditional Chinese medicines (TCMs) for molecular targeted therapies of tumours.

PubWeight™: 0.88‹?›

🔗 View Article (PMID 20156142)

Published in Curr Drug Discov Technol on March 01, 2010

Authors

Mahmoud Youns1, Jörg D Hoheisel, Thomas Efferth

Author Affiliations

1: Department of Pharmaceutical Biology, Institute of Pharmacy, University of Mainz, Staudinger Weg 5, Mainz, Germany.

Articles by these authors

ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome. Nat Methods (2007) 2.04

Genome-wide analysis of the response to cell wall mutations in the yeast Saccharomyces cerevisiae. J Biol Chem (2003) 1.99

Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells. Cancer Res (2010) 1.82

Cameroonian medicinal plants: pharmacology and derived natural products. Front Pharmacol (2010) 1.80

Chemotherapy-induced resistance by ATP-binding cassette transporter genes. Biochim Biophys Acta (2007) 1.79

Transcriptome analysis of differentiating trypanosomes reveals the existence of multiple post-transcriptional regulons. BMC Genomics (2009) 1.68

Targeted next-generation sequencing by specific capture of multiple genomic loci using low-volume microfluidic DNA arrays. Anal Bioanal Chem (2008) 1.68

Molecular principles of cancer invasion and metastasis (review). Int J Oncol (2009) 1.66

Heat shock causes a decrease in polysomes and the appearance of stress granules in trypanosomes independently of eIF2(alpha) phosphorylation at Thr169. J Cell Sci (2008) 1.64

Evidence-based Chinese medicine for cancer therapy. J Ethnopharmacol (2007) 1.47

Cytotoxicity of some Cameroonian spices and selected medicinal plant extracts. J Ethnopharmacol (2011) 1.46

Artesunate activates mitochondrial apoptosis in breast cancer cells via iron-catalyzed lysosomal reactive oxygen species production. J Biol Chem (2010) 1.41

Antimicrobial activity of clove and rosemary essential oils alone and in combination. Phytother Res (2007) 1.39

Microarray data warehouse allowing for inclusion of experiment annotations in statistical analysis. Bioinformatics (2002) 1.37

Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissue. PLoS One (2012) 1.36

Solid supports for microarray immunoassays. J Mol Recognit (2003) 1.33

Microarray-based detection of multidrug resistance in human tumor cells by expression profiling of ATP-binding cassette transporter genes. Cancer Res (2004) 1.32

Artesunate derived from traditional Chinese medicine induces DNA damage and repair. Cancer Res (2008) 1.31

Generation of high density protein microarrays by cell-free in situ expression of unpurified PCR products. Mol Cell Proteomics (2006) 1.28

Antibody microarrays: an evaluation of production parameters. Proteomics (2003) 1.28

Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate. Biochem Pharmacol (2004) 1.28

Modulation of human BCRP (ABCG2) activity by anti-HIV drugs. J Antimicrob Chemother (2007) 1.27

A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care. Oncotarget (2013) 1.27

Alterations in cardiac DNA methylation in human dilated cardiomyopathy. EMBO Mol Med (2013) 1.23

Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation. Clin Infect Dis (2008) 1.23

Glucose triggers different global responses in yeast, depending on the strength of the signal, and transiently stabilizes ribosomal protein mRNAs. Mol Microbiol (2003) 1.22

Dual-color proteomic profiling of complex samples with a microarray of 810 cancer-related antibodies. Mol Cell Proteomics (2010) 1.21

Use of CpG island microarrays to identify colorectal tumors with a high degree of concurrent methylation. Methods (2002) 1.21

Antibacterial activity and anticancer activity of Rosmarinus officinalis L. essential oil compared to that of its main components. Molecules (2012) 1.20

Artesunate in the treatment of metastatic uveal melanoma--first experiences. Oncol Rep (2005) 1.19

Optimal design of microarray immunoassays to compensate for kinetic limitations: theory and experiment. Mol Cell Proteomics (2006) 1.18

Cardiac ankyrin repeat protein, a negative regulator of cardiac gene expression, is augmented in human heart failure. Biochem Biophys Res Commun (2002) 1.17

The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo. Antiviral Res (2005) 1.14

Leishmaniasis: drug resistance and natural products (review). Int J Mol Med (2008) 1.13

Kinetics of antigen binding to antibody microspots: strong limitation by mass transport to the surface. Proteomics (2006) 1.13

The genome structure of Pseudomonas putida: high-resolution mapping and microarray analysis. Environ Microbiol (2002) 1.13

Anticancer activities of six selected natural compounds of some Cameroonian medicinal plants. PLoS One (2011) 1.12

ABCA3 as a possible cause of drug resistance in childhood acute myeloid leukemia. Clin Cancer Res (2006) 1.11

A community standard format for the representation of protein affinity reagents. Mol Cell Proteomics (2009) 1.11

Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an "in vitro" replicative system. Antiviral Res (2005) 1.10

Artesunate induces oxidative DNA damage, sustained DNA double-strand breaks, and the ATM/ATR damage response in cancer cells. Mol Cancer Ther (2011) 1.10

Antiviral effect of artemisinin from Artemisia annua against a model member of the Flaviviridae family, the bovine viral diarrhoea virus (BVDV). Planta Med (2006) 1.09

Functional genomics of stress response in Pseudomonas putida KT2440. J Bacteriol (2006) 1.09

Analysis of stage-specific gene expression in the bloodstream and the procyclic form of Trypanosoma brucei using a genomic DNA-microarray. Mol Biochem Parasitol (2002) 1.09

Polo-like kinase 1 as target for cancer therapy. Exp Hematol Oncol (2012) 1.09

Molecular biology of cantharidin in cancer cells. Chin Med (2007) 1.08

Correction of PCR-bias in quantitative DNA methylation studies by means of cubic polynomial regression. Nucleic Acids Res (2011) 1.08

Mode of cell death induction by pharmacological vacuolar H+-ATPase (V-ATPase) inhibition. J Biol Chem (2012) 1.08

First evidence that the antimalarial drug artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases. Int J Cancer (2010) 1.07

The RNA helicase DHH1 is central to the correct expression of many developmentally regulated mRNAs in trypanosomes. J Cell Sci (2010) 1.06

Role of transferrin receptor and the ABC transporters ABCB6 and ABCB7 for resistance and differentiation of tumor cells towards artesunate. PLoS One (2007) 1.06

Traditionally used Thai medicinal plants: in vitro anti-inflammatory, anticancer and antioxidant activities. J Ethnopharmacol (2010) 1.06

Functional analysis of Trypanosoma brucei PUF1. Mol Biochem Parasitol (2006) 1.05

What's in the genome of a filamentous fungus? Analysis of the Neurospora genome sequence. Nucleic Acids Res (2003) 1.05

Molecular interaction of artemisinin with translationally controlled tumor protein (TCTP) of Plasmodium falciparum. Biochem Pharmacol (2012) 1.05

DNA microarray analysis of pancreatic malignancies. Pancreatology (2004) 1.05

Cytotoxicity and modes of action of four Cameroonian dietary spices ethno-medically used to treat cancers: Echinops giganteus, Xylopia aethiopica, Imperata cylindrica and Piper capense. J Ethnopharmacol (2013) 1.04

MicroRNA expression profile of MCF-7 human breast cancer cells and the effect of green tea polyphenon-60. Cancer Genomics Proteomics (2010) 1.04

Cytotoxicity of Thymus vulgaris essential oil towards human oral cavity squamous cell carcinoma. Anticancer Res (2011) 1.04

Shikonin directly targets mitochondria and causes mitochondrial dysfunction in cancer cells. Evid Based Complement Alternat Med (2012) 1.02

The yeast transcriptome in aerobic and hypoxic conditions: effects of hap1, rox1, rox3 and srb10 deletions. Mol Microbiol (2002) 1.02

Cajanol, a novel anticancer agent from Pigeonpea [Cajanus cajan (L.) Millsp.] roots, induces apoptosis in human breast cancer cells through a ROS-mediated mitochondrial pathway. Chem Biol Interact (2010) 1.02

Effect of artemisinins and other endoperoxides on nitric oxide-related signaling pathway in RAW 264.7 mouse macrophage cells. Nitric Oxide (2008) 1.02

Expression profiling of glial genes during Drosophila embryogenesis. Dev Biol (2006) 1.01

Therapeutic and diagnostic applications of nanoparticles. Curr Drug Targets (2011) 1.00

Drug resistance in Plasmodium: natural products in the fight against malaria. Mini Rev Med Chem (2009) 1.00

Integration of GO annotations in Correspondence Analysis: facilitating the interpretation of microarray data. Bioinformatics (2005) 1.00

Antibody microarrays: promises and problems. Biotechniques (2002) 1.00

Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review). Int J Mol Med (2008) 0.98

Pancreatic cancer susceptibility loci and their role in survival. PLoS One (2011) 0.98

Pharmacogenomics of Cameroonian traditional herbal medicine for cancer therapy. J Ethnopharmacol (2011) 0.98

Multiplex approaches in protein microarray technology. Expert Rev Proteomics (2005) 0.97

Expression profile of genes in non-small cell lung carcinomas from long-term surviving patients. Clin Cancer Res (2002) 0.97

Antibody microarray-based profiling of complex specimens: systematic evaluation of labeling strategies. Proteomics (2007) 0.97

Sed1p and Srl1p are required to compensate for cell wall instability in Saccharomyces cerevisiae mutants defective in multiple GPI-anchored mannoproteins. Mol Microbiol (2004) 0.97

First study of oral Artenimol-R in advanced cervical cancer: clinical benefit, tolerability and tumor markers. Anticancer Res (2011) 0.97

Peptide nucleic acids on microarrays and other biosensors. Trends Biotechnol (2004) 0.96

Antioxidant activities and xanthine oxidase inhibitory effects of extracts and main polyphenolic compounds obtained from Geranium sibiricum L. J Agric Food Chem (2010) 0.95

Array-based analysis of genomic DNA methylation patterns of the tumour suppressor gene p16INK4A promoter in colon carcinoma cell lines. Nucleic Acids Res (2005) 0.95

Decoding pooled RNAi screens by means of barcode tiling arrays. BMC Genomics (2010) 0.95

A novel copper complex induces ROS generation in doxorubicin resistant Ehrlich ascitis carcinoma cells and increases activity of antioxidant enzymes in vital organs in vivo. BMC Cancer (2006) 0.95

Cytotoxicity and Modes of Action of the Methanol Extracts of Six Cameroonian Medicinal Plants against Multidrug-Resistant Tumor Cells. Evid Based Complement Alternat Med (2013) 0.95

P-glycoprotein and its inhibition in tumors by phytochemicals derived from Chinese herbs. J Ethnopharmacol (2011) 0.95

A radiosensitizing effect of artesunate in glioblastoma cells is associated with a diminished expression of the inhibitor of apoptosis protein survivin. Radiother Oncol (2012) 0.94

Single-molecule detection on a protein-array assay platform for the exposure of a tuberculosis antigen. J Proteome Res (2011) 0.94

Specialized DNA arrays for the differentiation of pancreatic tumors. Clin Cancer Res (2005) 0.94

Cytotoxicity and mode of action of four naturally occuring flavonoids from the genus Dorstenia: gancaonin Q, 4-hydroxylonchocarpin, 6-prenylapigenin, and 6,8-diprenyleriodictyol. Planta Med (2011) 0.93

Supercritical carbon dioxide extraction of seed oil from yellow horn (Xanthoceras sorbifolia Bunge.) and its anti-oxidant activity. Bioresour Technol (2009) 0.93

Antibody microarrays: the crucial impact of mass transport on assay kinetics and sensitivity. Expert Rev Mol Diagn (2006) 0.93

Creation of a minimal tiling path of genomic clones for Drosophila: provision of a common resource. Biotechniques (2004) 0.93

Cytotoxicity and modes of action of four naturally occuring benzophenones: 2,2',5,6'-tetrahydroxybenzophenone, guttiferone E, isogarcinol and isoxanthochymol. Phytomedicine (2013) 0.93

PNA microarrays for hybridisation of unlabelled DNA samples. Nucleic Acids Res (2003) 0.93

Oncoproteomic profiling with antibody microarrays. Genome Med (2009) 0.92

A transcriptome analysis of isoamyl alcohol-induced filamentation in yeast reveals a novel role for Gre2p as isovaleraldehyde reductase. FEMS Yeast Res (2006) 0.92

Optimization of luteolin separation from pigeonpea [Cajanus cajan (L.) Millsp.] leaves by macroporous resins. J Chromatogr A (2006) 0.92

Gene expression profiling identifies novel key players involved in the cytotoxic effect of Artesunate on pancreatic cancer cells. Biochem Pharmacol (2009) 0.92

Diagnostic values of GHSR DNA methylation pattern in breast cancer. Breast Cancer Res Treat (2012) 0.92

Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantation. Antiviral Res (2011) 0.91